CROI 2016 Program at a Glance

Disclosure Information

Jain,Vivek Institution: Grant support from Gilead Sciences Jensen, Bjoern-Erik Self: Board membershipViiV (past); payment for lectures fromViiV, Janssen-Cilag, Boehringer Ingelheim, Gilead, AbbVie, and Bristol-Myers Squibb (past) Kalayjian, Robert Self: Community advisory board, Sensor-Kinesis Corporation Kattakuzhy, Sarah Institution: Research grant from Gilead Khalilieh, Sauzanne Self: Employee of Merck Sharp & Dohme; may hold stock or stock options Institution: Research funding fromMerck & Co Kiser, Jennifer Spouse or Partner: Speaker for Astellas Institution: Research grant from Janssen Knox, David Self: Hororaria fromViiV Healthcare and Gilead Sciences Institution: Funding from Gilead Sciences Kouanfack, Charles Self: Board member for Bristol-Myers Squibb Krystal, Mark Self: Employee of Bristol-Myers Squibb La Rosa, Alberto Self: Employment at Janssen Peru LaCombe, Karine Self: Advisor for Bristol-Myers Squibb, Gilead, MSD, AbbVie, and Janssen Institution: Research grant from Gilead and Janssen Landovitz, Raphael Self: Consulting fees, travel, and drug supply from Gilead Sciences Letendre, Scott Self: Advisory board:ViiV Healthcare and Merck & Co Institution: Research funds from Gilead Sciences andViiV Healthcare Lingappa, Jairam Self: Scientific advisory board, Prosetta Antivirals Liu, Albert Self: Study drug and drug level testing provided by Self: Speaker honoraria from Pfizer and MSD, development of educational materials for TerraNova, consultant for Fujifilm Pharmaceuticals Spouse or Partner: Yes Institution: St George’s University of London, investigator-initiated research grant (Pfizer) Luetkemeyer, Anne Self: Advisor for and travel support from Bristol- Myers Squibb and Gilead Institution: Research grant support from AbbVie, Bristol-Myers Squibb, Gilead, Merck, and Pfizer Gilead Sciences Longley, Nicky

Mallon, Patrick Self: Honoraria, travel, and/or consultancy from Gilead Sciences, Bristol-Myers Squibb, ViiV Healthcare, Merck Sharpe & Dohme, and Janssen-Cilag Marcus, Julia Self: Research grant support fromMerck Margolis, David Self: Employee ofViiV Healthcare; stockholder in GSK Martrus, Gloria Self: Grant award from Gilead Mauss, Stefan Self: Scientific boards, review panels, and board membership for AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Roche, andViiV; speaker’s bureau for AbbVie, Bristol-Myers Squibb, Gilead, Roche, and Janssen; Consultant for AbbVie, Bristol-Myers Squibb Mayer, Kenneth Self: Research grants from Gilead Sciences andViiV McComsey, Grace Self: Employee, advisor to Gilead,ViiV, Bristol- Myers Squibb, and ICON Institution: Grant support from Gilead,ViiV, Bristol-Myers Squibb, and AstraZeneca McGowan, Ian Self: Advisor, Abivax and Novicol Life Sciences Institution: Research grant from Janssen R&D Meissner, Eric Institution: Support from Gilead Sciences Merat, Sabrina Self: Employee of AIMMTherapeutics Institution: AIMMTherapeutics is a joint venture of IMMPACT and the Academic Medical Center at the University of Amsterdam Mirochnick, Mark Self: Consultant for Merck; DSMB member, Merck andViiV Mogalian, Erik Self: Employee of Gilead Sciences Molina, Jean-Michel Self: Advisory board for Gilead, Merck,ViiV, Janssen, and Bristol-Myers Squibb; grants from Merck and Gilead Murray, Miranda Self: Employee ofViiV Healthcare Naggie, Susanna Self: Advisor for Gilead, AbbVie, Bristol-Myers Squibb, Janssen,Vertex, and Merck Institution: Research grants from Gilead, AbbVie, Bristol-Myers Squibb, Janssen,Vertex, and Merck Newton, Alicia Self: Consultant for Monogram Biosciences Obermeier, Martin Institution: Research grant from Hologic

Gisslén, Magnus Self: Research grants from Abbott/AbbVie, Baxter, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Roche, andTibotec; honoraria as speaker and/or scientific advisor from Abbott/AbbVie, Bioinvent, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV, Janssen-Cilag, Merck, Pfizer, Roche, andTibotec Golub, Sarit Self: Study drug from Gilead Gottlieb, Geoffrey Self: Research support from Gilead Sciences, Alere, and Abbott Molecular Diagnostics Grant, Alison Self: Validation panels from Alere Grant, Robert Self: Study medication from Gilead Sciences Grobbler, Jay Disclosure will be provided prior to the presentation Hamzah, Lisa Self: Funding to attend conferences from Gilead Sciences and honoraria from Janssen-Cilag Harrigan, P. Richard Self: Grants from, advisor to, or speaker for events sponsored by Pfizer, GlaxoSmithKline, Abbott, Merck,TobiraTherapeutics,Virco, and Quest Diagnostics; consultant forViiV Healthcare, TobiraTherapeutics, Selah Genomics, and Quest Diagnostics; stockholder in Merck, Illumina, Gilead, and EKF Diagnostics; funding support from CIHR/ GSK Research Chair in ClinicalVirology Institution: Contracts to perform drug-resistance testing for Merck,ViiV, and Janssen Harris, Reuben Self: Cofounder of ApoGen Biotechnologies Heath, Sonya Self: Advisor for and grant fromMerck Institution: Research award fromMerck Hernandez, Dennis Self: Employee of Bristol-Myers Squibb Hoenigl, Martin Self: Speaker honorarium fromMerck Institution: Funding from Gilead Hsue, Priscilla Self: Honoraria from Gilead, Merck, and Bristol- Myers Squibb Huang,Wei Self: Employee of Monogram Biosciences Huhn, Gregory Self: Consultant for Gilead Sciences and ViiV; therapeutic advisor for Practice Point Communications Hunt, Peter Self: Consultant for Merck, Gilead, andViiV

Disclsoure Information

CROI 2016 129